11/27/2024
5:04 PM | Acrivon Therapeutics (Issuer)
Blume-Jensen Peter (Reporting)
Masson Kristina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:06 PM | Acrivon Therapeutics (Issuer)
Devroe Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:08 PM | Acrivon Therapeutics (Issuer)
Gamelin Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:10 PM | Acrivon Therapeutics (Issuer)
Holm-Jorgensen Rasmus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:11 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
6:06 AM | Acrivon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
6:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
3:22 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
7:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
5:49 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
5:43 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ACRV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/16/2024
3:52 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
3:53 PM | Acrivon Therapeutics (Issuer)
Peterson Katharine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
7:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:36 AM | Acrivon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024
3:20 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
7:29 PM | Acrivon Therapeutics (Subject)
Chione Ltd (Filed by)
| Form SC 13G/A | |
07/10/2024
7:34 PM | Acrivon Therapeutics (Subject)
Chione Ltd (Filed by)
| Form SC 13G/A | |
06/24/2024
4:36 PM | Acrivon Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
4:26 PM | Acrivon Therapeutics (Issuer)
BAUM CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
4:27 PM | Acrivon Therapeutics (Issuer)
DiRocco Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
4:27 PM | Acrivon Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
4:28 PM | Acrivon Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:56 PM | Acrivon Therapeutics (Issuer)
Devroe Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:58 PM | Acrivon Therapeutics (Issuer)
Gamelin Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:00 PM | Acrivon Therapeutics (Issuer)
Holm-Jorgensen Rasmus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:02 PM | Acrivon Therapeutics (Issuer)
Masson Kristina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:03 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:05 PM | Acrivon Therapeutics (Issuer)
Peterson Katharine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:52 PM | Acrivon Therapeutics (Issuer)
Peterson Katharine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/16/2024
5:54 PM | Acrivon Therapeutics (Issuer)
Blume-Jensen Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
7:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
6:31 AM | Acrivon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
11:15 PM | Acrivon Therapeutics (Filer)
| Form EFFECT | |
04/26/2024
7:30 AM | Acrivon Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
7:30 AM | Acrivon Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
7:33 AM | Acrivon Therapeutics (Filer)
Acrivon Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
7:36 AM | Acrivon Therapeutics (Filer)
Acrivon Therapeutics (Filer)
| Form ARS | |
04/17/2024
3:39 PM | Acrivon Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/15/2024
7:53 AM | Acrivon Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
7:21 AM | Acrivon Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
Has Trump finally met his match? (Ad) Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again? Click here for his emergency broadcast... |
04/11/2024
3:16 PM | Acrivon Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
04/09/2024
6:05 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
8:06 AM | Acrivon Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/28/2024
7:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
6:36 AM | Acrivon Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
3:32 PM | Acrivon Therapeutics (Issuer)
Palani Santhosh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
7:15 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
4:13 PM | Acrivon Therapeutics (Issuer)
Masson Kristina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
4:14 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:57 PM | Acrivon Therapeutics (Subject)
CITADEL ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
3:36 PM | Acrivon Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
8:51 AM | Acrivon Therapeutics (Subject)
Marshall Wace North America L.P. (Filed by)
| Form SC 13G/A | |
02/13/2024
2:40 PM | Acrivon Therapeutics (Subject)
Sands Capital Ventures, LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
3:37 PM | Acrivon Therapeutics (Issuer)
Magovcevic-Liebisch Ivana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
3:34 PM | Acrivon Therapeutics (Issuer)
Magovcevic-Liebisch Ivana (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
7:27 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
